<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>8(1)</volume><submitter>Pourseif MM</submitter><pubmed_abstract>&lt;i>&lt;b>Introduction:&lt;/b>&lt;/i> In this study, we targeted the worm stage of &lt;i>Echinococcus granulosus&lt;/i> to design a novel multi-epitope B- and helper T-cell based vaccine construct for immunization of dogs against this multi-host parasite. &lt;i>&lt;b>Methods:&lt;/b>&lt;/i> The vaccine was designed based on the local Eg14-3-3 antigen (Ag). DNA samples were extracted from the protoscoleces of the infected sheep's liver, and then subjected to the polymerase chain reaction (PCR) with 14-3-3 specific forward and reverse primers. For the vaccine designing, several &lt;i>in silico&lt;/i> steps were undertaken. Three-dimensional (3D) structure of the local Eg14-3-3 Ag was modeled by EasyModeller software. The protein modeling accuracy was then analyzed via various validation assays. Potential transmembrane helix, </pubmed_abstract><journal>BioImpacts : BI</journal><pagination>39-52</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5915707</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>A novel B- and helper T-cell epitopes-based prophylactic vaccine against &lt;i>Echinococcus granulosus&lt;/i>.</pubmed_title><pmcid>PMC5915707</pmcid><pubmed_authors>Nematollahi A</pubmed_authors><pubmed_authors>Daghighkia H</pubmed_authors><pubmed_authors>Moghaddam G</pubmed_authors><pubmed_authors>Omidi Y</pubmed_authors><pubmed_authors>Pourseif MM</pubmed_authors></additional><is_claimable>false</is_claimable><name>A novel B- and helper T-cell epitopes-based prophylactic vaccine against &lt;i>Echinococcus granulosus&lt;/i>.</name><description>&lt;i>&lt;b>Introduction:&lt;/b>&lt;/i> In this study, we targeted the worm stage of &lt;i>Echinococcus granulosus&lt;/i> to design a novel multi-epitope B- and helper T-cell based vaccine construct for immunization of dogs against this multi-host parasite. &lt;i>&lt;b>Methods:&lt;/b>&lt;/i> The vaccine was designed based on the local Eg14-3-3 antigen (Ag). DNA samples were extracted from the protoscoleces of the infected sheep's liver, and then subjected to the polymerase chain reaction (PCR) with 14-3-3 specific forward and reverse primers. For the vaccine designing, several &lt;i>in silico&lt;/i> steps were undertaken. Three-dimensional (3D) structure of the local Eg14-3-3 Ag was modeled by EasyModeller software. The protein modeling accuracy was then analyzed via various validation assays. Potential transmembrane helix, </description><dates><release>2018-01-01T00:00:00Z</release><publication>2018</publication><modification>2026-05-01T01:55:09.378Z</modification><creation>2019-03-26T23:36:27Z</creation></dates><accession>S-EPMC5915707</accession><cross_references><pubmed>29713601</pubmed><doi>10.15171/bi.2018.06</doi></cross_references></HashMap>